The US FDA is interested in using opioid labels to mandate packaging standards, as well as offer claims similar to those available for abuse-deterrent products.
Commissioner Scott Gottlieb said Dec
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?